Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma

Lorenzo Falchi; Martin Hutchings; Carmelo Carlo-Stella; Franck Morschhauser; Michael Dickinson; Guillaume Cartron; Cyrus Khan; Monica Tani; Joaquin Martinez-Lopez; Nancy L Bartlett; Antonio Salar; Joshua D Brody; Sirpa Leppä; Aurelien Berthier; Martine Kallemeijn; James Relf; Fabiola Bene Tchaleu; Linda Lundberg; Emmanuel Bachy

doi:10.3324/haematol.2024.286257

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma

Lorenzo Falchi^*
, Martin Hutchings
, Carmelo Carlo-Stella
, Franck Morschhauser
, Michael Dickinson
, Guillaume Cartron
, Cyrus Khan
, Monica Tani
, Joaquin Martinez-Lopez
, Nancy L Bartlett
, Antonio Salar
, Joshua D Brody
, Sirpa Leppä
, Aurelien Berthier
, Martine Kallemeijn
, James Relf
, Fabiola Bene Tchaleu
, Linda Lundberg
, Emmanuel Bachy

^*Corresponding author af dette arbejde

Afdeling for Blodsygdomme CKO

8 Citationer (Scopus)

Abstract

Not available.

Originalsprog	Engelsk
Tidsskrift	Haematologica
Vol/bind	110
Udgave nummer	4
Sider (fra-til)	999-1004
Antal sider	6
ISSN	0390-6078
DOI	https://doi.org/10.3324/haematol.2024.286257
Status	Udgivet - 1 apr. 2025

Adgang til dokumentet

10.3324/haematol.2024.286257

Andre filer og links

Link to publication in Scopus

Fingeraftryk

Dyk ned i forskningsemnerne om 'Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Falchi, L., Hutchings, M., Carlo-Stella, C., Morschhauser, F., Dickinson, M., Cartron, G., Khan, C., Tani, M., Martinez-Lopez, J., Bartlett, N. L., Salar, A., Brody, J. D., Leppä, S., Berthier, A., Kallemeijn, M., Relf, J., Tchaleu, F. B., Lundberg, L., & Bachy, E. (2025). Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma. Haematologica, 110(4), 999-1004. https://doi.org/10.3324/haematol.2024.286257

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma. / Falchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo et al.
I: Haematologica, Bind 110, Nr. 4, 01.04.2025, s. 999-1004.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Falchi, L, Hutchings, M, Carlo-Stella, C, Morschhauser, F, Dickinson, M, Cartron, G, Khan, C, Tani, M, Martinez-Lopez, J, Bartlett, NL, Salar, A, Brody, JD, Leppä, S, Berthier, A, Kallemeijn, M, Relf, J, Tchaleu, FB, Lundberg, L & Bachy, E 2025, 'Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma', Haematologica, bind 110, nr. 4, s. 999-1004. https://doi.org/10.3324/haematol.2024.286257

Falchi L, Hutchings M, Carlo-Stella C, Morschhauser F, Dickinson M, Cartron G et al. Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma. Haematologica. 2025 apr. 1;110(4):999-1004. Epub 2024 nov. 28. doi: 10.3324/haematol.2024.286257

@article{ba805e7f603b4838b206d1d9b6942e0c,

title = "Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma",

abstract = "Not available.",

author = "Lorenzo Falchi and Martin Hutchings and Carmelo Carlo-Stella and Franck Morschhauser and Michael Dickinson and Guillaume Cartron and Cyrus Khan and Monica Tani and Joaquin Martinez-Lopez and Bartlett, \{Nancy L\} and Antonio Salar and Brody, \{Joshua D\} and Sirpa Lepp{\"a} and Aurelien Berthier and Martine Kallemeijn and James Relf and Tchaleu, \{Fabiola Bene\} and Linda Lundberg and Emmanuel Bachy",

year = "2025",

month = apr,

day = "1",

doi = "10.3324/haematol.2024.286257",

language = "English",

volume = "110",

pages = "999--1004",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "4",

}

TY - JOUR

T1 - Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed / refractory large B-cell lymphoma

AU - Falchi, Lorenzo

AU - Hutchings, Martin

AU - Carlo-Stella, Carmelo

AU - Morschhauser, Franck

AU - Dickinson, Michael

AU - Cartron, Guillaume

AU - Khan, Cyrus

AU - Tani, Monica

AU - Martinez-Lopez, Joaquin

AU - Bartlett, Nancy L

AU - Salar, Antonio

AU - Brody, Joshua D

AU - Leppä, Sirpa

AU - Berthier, Aurelien

AU - Kallemeijn, Martine

AU - Relf, James

AU - Tchaleu, Fabiola Bene

AU - Lundberg, Linda

AU - Bachy, Emmanuel

PY - 2025/4/1

Y1 - 2025/4/1

N2 - Not available.

AB - Not available.

UR - https://www.scopus.com/pages/publications/105001641823

U2 - 10.3324/haematol.2024.286257

DO - 10.3324/haematol.2024.286257

M3 - Comment/debate

C2 - 39605203

SN - 0390-6078

VL - 110

SP - 999

EP - 1004

JO - Haematologica

JF - Haematologica

IS - 4

ER -